Lipid vascular wall interaction

被引:7
作者
Allen, S [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Heart Sci Ctr, NHLI,Dept Cardiothorac Surg, Harefield UB9 6JH, Middx, England
关键词
D O I
10.1097/00001573-199811000-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is an extremely complex process that involves the interaction of a large number of genes as well as environmental factors: a chronic inflammatory cascade that can be converted to an acute clinical event by the induction of plaque rupture, which, in turn, leads to thrombosis. What are the basic mechanisms that induce this sequence of events? For many years, atherosclerosis research concentrated on the role played by circulating lipids. Many clinical trials have demonstrated that interventions aimed at lowering lipid levels have beneficial effects in terms of reduction in the incidence of cardiac events and in mortality from coronary artery disease. To account for these clinical benefits that have been observed even with relatively short periods of intervention, several hypotheses, such as halting plaque progression and stabilizing rupture-prone lesions, have been suggested. The mechanisms responsible for these observations, however, remain poorly understood. This review focuses on 1) identifying the different lipid components that interact with the vessel wall, 2) defining the different endothelial lipoprotein receptors that bind and transfer the lipid into the cell, and 3) explaining the mechanisms of lipid atherogenicity.
引用
收藏
页码:439 / 446
页数:8
相关论文
共 70 条
  • [1] Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells
    Allen, S
    Khan, S
    Futwan-Al-Mohanna
    Batten, P
    Yacoub, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) : 1064 - 1075
  • [2] Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans
    Anber, V
    Millar, JS
    McConnell, M
    Shepherd, J
    Packard, CJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 2507 - 2514
  • [3] LIPOPROTEIN(A) AND ACCELERATED CORONARY-ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS
    BARBIR, M
    KUSHWAHA, S
    HUNT, B
    MACKEN, A
    THOMPSON, GR
    MITCHELL, A
    ROBINSON, D
    YACOUB, M
    [J]. LANCET, 1992, 340 (8834-5) : 1500 - 1502
  • [4] Determinants of transplant-related coronary calcium detected by ultrafast computed tomography scanning
    Barbir, M
    Lazem, F
    Bowker, T
    Ludman, P
    Banner, N
    Mitchell, A
    Yacoub, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (12) : 1606 - 1609
  • [5] BATTEY FD, 1994, J BIOL CHEM, V269, P23268
  • [6] INTERACTION OF LIPOPROTEIN LP(A) AND LOW-DENSITY LIPOPROTEIN WITH GLYCOSAMINOGLYCANS FROM HUMAN AORTA
    BIHARIVARGA, M
    GRUBER, E
    ROTHENEDER, M
    ZECHNER, R
    KOSTNER, GM
    [J]. ARTERIOSCLEROSIS, 1988, 8 (06): : 851 - 857
  • [7] THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS
    BJORKHEM, I
    HENRIKSSONFREYSCHUSS, A
    BREUER, O
    DICZFALUSY, U
    BERGLUND, L
    HENRIKSSON, P
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 15 - 22
  • [8] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS
    BROWN, MS
    GOLDSTEIN, JL
    [J]. SCIENCE, 1986, 232 (4746) : 34 - 47
  • [9] RECEPTOR-MEDIATED CONTROL OF CHOLESTEROL-METABOLISM
    BROWN, MS
    GOLDSTEIN, JL
    [J]. SCIENCE, 1976, 191 (4223) : 150 - 154
  • [10] THE SCAVENGER CELL PATHWAY FOR LIPOPROTEIN DEGRADATION - SPECIFICITY OF THE BINDING-SITE THAT MEDIATES THE UPTAKE OF NEGATIVELY-CHARGED LDL BY MACROPHAGES
    BROWN, MS
    BASU, SK
    FALCK, JR
    HO, YK
    GOLDSTEIN, JL
    [J]. JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1980, 13 (01): : 67 - 81